Work

Randomized, Double-Blind, Placebo-Controlled Study of Sitaxsentan to Improve Impaired Exercise Tolerance in Patients With Heart Failure and a Preserved Ejection Fraction

Year: 2014

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: JACC Heart Failure

DOI: 10.1016/j.jchf.2013.12.002

Authors: Michael R. Zile, Robert C. Bourge, Margaret M. Redfield, Duo Zhou, Catalin F. Baicu, William C. Little

Institutions: Medical University of South Carolina, Ralph H. Johnson VA Medical Center, University of Alabama at Birmingham, UAB Medicine, Mayo Clinic, Pfizer (United States), University of Mississippi Medical Center

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Veterans Affairs, Pfizer

Awards: G2759414028, G8663854189, G99361962

OpenAlex ID: W2013848755

FWCI: 7.31

Cites: 37

Cited by: 78

Related to: 10